Lu Gram joined the Institute for Global Health at UCL in 2013 to pursue a PhD on women’s empowerment in a complex public health trial in Nepal (LBW-SAT). His main research interest lies in the promotion of gender equality and women’s empowerment and the intersection between women’s empowerment, economics and public health. Before joining IGH, he has worked with London School of Hygiene and Tropical Medicine on a number of large-scale public health trials in Africa and South Asia on topics including newborn vitamin A on the first 6 months’ of life, simplified antibiotic regimens for treatment of neonatal sepsis, technological and community-based alternatives to health worker motivation and the promotion of child survival, growth and development through home visits. He is currently based in London, but spends part of the year on project work in Nepal.
The Low Birth Weight South Asia Trial (LBWSAT): a cluster-randomised controlled trial in Nepal of impact on birth weight of an enhanced nutrition behaviour change strategy through women’s groups and home visits, with and without unconditional transfers of fortified food or cash during pregnancy (2016)
Simplified antibiotic regimens compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with clinical signs of possible serious bacterial infection when referral is not possible: a randomised, open-label, equivalence trial (2015)
Oral amoxicillin compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with fast breathing when referral is not possible: a randomised, open-label, equivalence trial (2015)
Treatment of fast breathing in neonates and young Infants with oral amoxicillin compared to injectable penicillin-gentamicin combination: Study protocol for a randomized, open-label equivalence trial (2013)
Simplified regimens for management of neonates and young infants with clinical severe infection in situations when hospital admission is not possible: Study protocol for a randomized, open-label equivalence trial (2013)